Matches in Wikidata for { <http://www.wikidata.org/entity/Q93176407> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q93176407 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q93176407 description "scientific article published on 01 December 2019" @default.
- Q93176407 description "wetenschappelijk artikel" @default.
- Q93176407 description "наукова стаття, опублікована 1 грудня 2019" @default.
- Q93176407 description "գիտական հոդված հրատարակված 2019 թվականի դեկտեմբերի 1-ին" @default.
- Q93176407 name "A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat" @default.
- Q93176407 name "A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat" @default.
- Q93176407 type Item @default.
- Q93176407 label "A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat" @default.
- Q93176407 label "A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat" @default.
- Q93176407 prefLabel "A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat" @default.
- Q93176407 prefLabel "A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat" @default.
- Q93176407 P1433 Q93176407-8AD9855B-658C-4D9E-93DA-95EC08D09A55 @default.
- Q93176407 P1476 Q93176407-6D14A691-CF7E-4B58-BA9B-2227C05919E5 @default.
- Q93176407 P2093 Q93176407-18781893-6C3B-49A8-9498-E24E3D9E4253 @default.
- Q93176407 P2093 Q93176407-2A47E3FE-4370-4669-8A2E-000E23D6DA36 @default.
- Q93176407 P2093 Q93176407-2FCEC958-1070-45A0-8041-33210E3AE738 @default.
- Q93176407 P2093 Q93176407-6917048B-B09A-41A9-BA8C-A08256B34411 @default.
- Q93176407 P2093 Q93176407-9DDCC9EB-F124-48E6-98F1-E72529952C2D @default.
- Q93176407 P2093 Q93176407-A285FD3C-53D8-40AE-8A38-33444D97C0E0 @default.
- Q93176407 P2093 Q93176407-C24A3398-2B0D-45CD-9816-BCB3CB80EDF7 @default.
- Q93176407 P2093 Q93176407-D163B952-F71F-4983-BA2B-1458D688359E @default.
- Q93176407 P304 Q93176407-AE3C5CD4-65C9-4F9B-BB62-6EFA77E7B43C @default.
- Q93176407 P31 Q93176407-D181A2C2-DAF2-47B8-B02A-24006817C2A1 @default.
- Q93176407 P356 Q93176407-9F9C3440-6582-4486-B450-21792997F8F3 @default.
- Q93176407 P433 Q93176407-9C317DD9-7315-4123-A9EC-555EBEB755C8 @default.
- Q93176407 P478 Q93176407-CBDAE239-6256-4BA2-9912-89E808F39BB8 @default.
- Q93176407 P577 Q93176407-6E521B63-7885-450C-93E9-187984917C03 @default.
- Q93176407 P698 Q93176407-8C732667-8313-4744-8DEA-D72C4B1DB611 @default.
- Q93176407 P921 Q93176407-E09A44F5-718A-46CC-89B1-7C873EEA0AB2 @default.
- Q93176407 P356 DSS.0000000000001850 @default.
- Q93176407 P698 30998531 @default.
- Q93176407 P1433 Q15752669 @default.
- Q93176407 P1476 "A Double-Blind, Placebo-Controlled, Phase 3b Study of ATX-101 for Reduction of Mild or Extreme Submental Fat" @default.
- Q93176407 P2093 "Beta Bowen" @default.
- Q93176407 P2093 "Dee Anna Glaser" @default.
- Q93176407 P2093 "Jeffrey S Dover" @default.
- Q93176407 P2093 "Jeremy B Green" @default.
- Q93176407 P2093 "Laura Breshears" @default.
- Q93176407 P2093 "Richard G Glogau" @default.
- Q93176407 P2093 "Steve Yoelin" @default.
- Q93176407 P2093 "Valerie D Callender" @default.
- Q93176407 P304 "1531-1541" @default.
- Q93176407 P31 Q13442814 @default.
- Q93176407 P356 "10.1097/DSS.0000000000001850" @default.
- Q93176407 P433 "12" @default.
- Q93176407 P478 "45" @default.
- Q93176407 P577 "2019-12-01T00:00:00Z" @default.
- Q93176407 P698 "30998531" @default.
- Q93176407 P921 Q269829 @default.